OUR MISSION

We are fighting to put lifesaving medication into the hands of everyone who needs it

Right now, we have highly effective tools to end the HIV epidemic once and for all. But after more than a decade since the first medication for PrEP was approved by the FDA, only 24% of Hispanic/Latinx people and 13% of Black people who could benefit most from PrEP are using it, while 94% of white individuals who could benefit have access. 

We pride ourselves on our ability to take data-driven policy solutions and use them to build movements. We’re identifying the laws, science, and research that empower the United States government to make HIV medication available to everyone who needs it, using that knowledge to hold our policymakers accountable, and driving the movement to finally establish a National PrEP Program for un- and underinsured populations. 

OUR STORY

Effective activism can
save lives

Founded in March 2018, PrEP4All is an organization of community members, healthcare professionals, lawyers, and academics all dedicated to increasing access to lifesaving HIV medication. Every member of PrEP4All has been personally affected by the HIV epidemic, and most of us rely on HIV medications every day. As patients ourselves, we have all experienced the shortcomings in the domestic HIV response first hand, whether through arguing with insurance companies refusing to cover our medication, encountering doctors unwilling to refill our prescriptions, or receiving an unexpected bill for $1,800 after our copay assistance has run out. Our biggest strength is our personal experience.

In the tradition of activism blazed by ACT UP in the 1980s, PrEP4All uses direct action, media, and political advocacy to lower the price of PrEP and ensure universal access to HIV prevention and treatment.

In 2019, the U.S. government set a goal to reduce annual HIV infections by 90% by 2030. Despite this, a new person in the U.S. is diagnosed with HIV every 15 minutes. More often than not, that person is LGBTQ+, low-income, and a person of color. Meanwhile, Gilead Sciences, the first manufacturer of PrEP, charges up to $2,000 a month for the drug despite it costing less than $6 per month in other countries. Gilead’s profiteering has hamstrung the HIV response in the U.S., despite PrEP being a government-funded invention.

success

August 2024

After nearly two years of advocacy from PrEP4All, the Centers for Disease Control and Prevention released a $7 million notification of funding opportunity for a pilot of the National PrEP Program in four jurisdictions. For the first time ever, CDC will allow funds to go toward highly affordable generic PrEP medications. Along with our previous win in pressing for CDC funds to go toward PrEP labs, we have successfully opened the door for the first time to simple, uncomplicated access to comprehensive PrEP services.

July 2024

In response to PrEP4All, HHS begins the process of winding down the poorly conceived federal Ready Set PrEP program which has been wasting tens of millions of Minority AIDS Initiative dollars each year and recently raised privacy concerns among advocates.

June 2024

Following setbacks in the US v. Gilead case in May 2023, PrEP4All advocates for further government action, which the Department of Justice ultimately heeds in June of 2024 by appealing the case. PrEP4All is committed to see this case through until justice is served for our communities.

March 2024

Thanks to advocacy led by PrEP4All and our partners, $767 million in proposed cuts to domestic HIV funds are averted, with Congress including calls to establish a National PrEP Program.

October 2023

President Biden publicly calls for a National PrEP Program in a speech following meetings convened by PrEP4All with senior administration staff; further elevating the PrEP for All to End the HIV Epidemic initiative that has been included in the Presidents FY23, FY24, and FY25 Budget Requests.

September 2023

PrEP4All launches #SaveHIVFunding campaign, organizes a full press conference outside of the US Capitol, and mobilizes over 150 HIV organizations to denounce drastic cuts to domestic and global HIV funding.

July 2023

PrEP4All and allies successfully advocate for Senate bill that would increase funding to CDC to specifically “support[s] the building blocks for a national program to increase…PrEP.”

December 2022

Heeding PrEP4All’s advocacy, Congress includes a $25M increase to funding to CDC to go toward equitable PrEP access. Our advocacy also preserved that increase for an additional $25M the following year.

July/August 2022

PrEP4All raises media awareness and organizes protests at International AIDS Conference in Montreal, Canada to pressure Biden Administration to release a stockpile of vaccines to prevent vulnerable populations from acquiring mpox.

April 2022

Biden Administration included funding for PrEP For All To End The HIV Epidemic program in FY 2023 budget after PrEP4All released white paper outlining implementation recommendations for a federally-funded national PrEP program.

January 2021

Working with a team from NYU Law School, we released a user’s guide to government patent use for the new Biden administration to take on lowering drug prices.

September 2020

We drew 250,000+ participants to a virtual event with experts and policymakers to call on the Trump Administration to intervene and end remdesivir shortages.

March 2019

We organized a U.S. Congressional Committee on Oversight and Reform hearing where representatives questioned Gilead’s CEO bout the company’s price gouging.

our team

Team Img
Jeremiah JohnsonHE/HIM
EXECUTIVE DIRECTOR
Team Img
Michael ChancleyHe/Him
Communications & Mobilization Manager
Team Img
Amy Killelea
Senior Policy Advisor, HIV Prevention

our board

Board Img
Tim HornHE/HIM
CO-CHAIR
Board Img
Moisés Agosto-RosarioHE/HIM
CO-CHAIR
Board Img
Peter StaleyHE/HIM
MEMBER
Board Img
Milton Rodríguez PadillaHE/HIM
MEMBER